Liminatus Pharma(LIMN.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Liminatus Pharma
LIMN.US
Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.
1.820 T
LIMN.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    12 Health Care Stocks Moving In Thursday's Intraday Session

    benzinga_article·
    US
    LIMN
    +1.55%
    US
    CDNA
    -0.29%
    US
    QDEL
    +4.98%
    benzinga_article·
    US
    LIMN
    +1.55%
    US
    CDNA
    -0.29%
    US
    QDEL
    +4.98%

    U.S. stock market midday update: Liminatus Pharma up 15.09%, trading volume surges, market sentiment is high but beware of volatility risks

    Price Alert·
    US
    LIMN
    +1.55%
    Price Alert·
    US
    LIMN
    +1.55%

    Liminatus Pharma | 10-K: FY2025 Revenue: USD 0

    Earnings Watch·
    US
    LIMN
    +1.55%
    Earnings Watch·
    US
    LIMN
    +1.55%

    Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody | LIMN Stock News

    StockTitan·
    US
    LIMN
    +1.55%
    US
    PBE
    +0.11%
    US
    BBH
    +0.68%
    StockTitan·
    US
    LIMN
    +1.55%
    US
    PBE
    +0.11%
    US
    BBH
    +0.68%

    12 Health Care Stocks Moving In Tuesday's Intraday Session

    benzinga_article·
    US
    LIMN
    +1.55%
    US
    IBBQ
    +0.07%
    US
    BIB
    +0.05%
    benzinga_article·
    US
    LIMN
    +1.55%
    US
    IBBQ
    +0.07%
    US
    BIB
    +0.05%
    © 2026 Longbridge｜Disclaimer